Strains

Limosilactobacillus reuteri

NOVI-51

L. reuteri  is widely known for having a positive impact on infant health. In trial, NOVI-51 demonstrated improvement of infant colic in babies when consumed during the last trimester of pregnancy.

Benefits of NOVI-51:

  • Probiotic support for mom and baby

  • Helps prevent colic

  • Supports digestive health

  • Clinically proven to improve infant colic via prenatal administration

  • Being consumed by expectant mothers in the last trimester of pregnancy, NOVI-51 is effective from birth

  • Benefits have also been proven clinically significant for babies born via C-section

  • The low daily dosage allows for NOVI-51 to be easily incorporated into existing pre-natal formulations which include other vital nutrients for pregnant mothers

Clinical Dosage for NOVI-51:

0,1 billion CFU per day

4725 Tradewinds Parkway
Madison, WI 53718

Follow